Peltonen M - Search Results

1

A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol.

Barbera M, Lehtisalo J, Perera D, Aspö M, Cross M, De Jager Loots CA, Falaschetti E, Friel N, Luchsinger JA, Gavelin HM, Peltonen M, Price G, Neely AS, Thunborg C, Tuomilehto J, Mangialasche F, Middleton L, Ngandu T, Solomon A, Kivipelto M; MET-FINGER study team. Barbera M, et al. Among authors: peltonen m. Alzheimers Res Ther. 2024 Jan 31;16(1):23. doi: 10.1186/s13195-023-01355-x. Alzheimers Res Ther. 2024. PMID: 38297399 Free PMC article.

2

The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women.

Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P. Hu G, et al. Among authors: peltonen m. Int J Obes (Lond). 2005 Aug;29(8):894-902. doi: 10.1038/sj.ijo.0802870. Int J Obes (Lond). 2005. PMID: 15724141

3

The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease.

Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. Hu G, et al. Among authors: peltonen m. J Am Coll Cardiol. 2005 May 3;45(9):1413-8. doi: 10.1016/j.jacc.2005.01.039. J Am Coll Cardiol. 2005. PMID: 15862411 Free article.

4

Lifestyle strategies for weight control: experience from the Finnish Diabetes Prevention Study.

Lindström J, Peltonen M, Tuomilehto J. Lindström J, et al. Among authors: peltonen m. Proc Nutr Soc. 2005 Feb;64(1):81-8. doi: 10.1079/pns2004412. Proc Nutr Soc. 2005. PMID: 15877926 Review.

5

Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland.

Hu G, Jousilahti P, Peltonen M, Lindström J, Tuomilehto J. Hu G, et al. Among authors: peltonen m. Diabetologia. 2005 Aug;48(8):1477-83. doi: 10.1007/s00125-005-1824-1. Epub 2005 Jun 22. Diabetologia. 2005. PMID: 15971060

6

Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.

Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J. Saaristo T, et al. Among authors: peltonen m. Diab Vasc Dis Res. 2005 May;2(2):67-72. doi: 10.3132/dvdr.2005.011. Diab Vasc Dis Res. 2005. PMID: 16305061 Free article.

7

High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study.

Lindström J, Peltonen M, Eriksson JG, Louheranta A, Fogelholm M, Uusitupa M, Tuomilehto J. Lindström J, et al. Among authors: peltonen m. Diabetologia. 2006 May;49(5):912-20. doi: 10.1007/s00125-006-0198-3. Epub 2006 Mar 16. Diabetologia. 2006. PMID: 16541277 Free article. Clinical Trial.

8

Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland.

Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J. Hu G, et al. Among authors: peltonen m. Int J Obes (Lond). 2006 Dec;30(12):1742-9. doi: 10.1038/sj.ijo.0803341. Epub 2006 Apr 25. Int J Obes (Lond). 2006. PMID: 16652136

9

Association of leisure time physical activity and abdominal obesity with fasting serum insulin and 2-h postchallenge plasma glucose levels.

Borodulin K, Tuomilehto J, Peltonen M, Lakka TA, Sundvall J, Jousilahti P. Borodulin K, et al. Among authors: peltonen m. Diabet Med. 2006 Sep;23(9):1025-8. doi: 10.1111/j.1464-5491.2006.01897.x. Diabet Med. 2006. PMID: 16922711

10

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group. Lindström J, et al. Among authors: peltonen m. Lancet. 2006 Nov 11;368(9548):1673-9. doi: 10.1016/S0140-6736(06)69701-8. Lancet. 2006. PMID: 17098085 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters